in a double-blind , prospective , randomized clinical study , perorally administered ciprofloxacin was compared with intravenously administered cefotaxime in the treatment of skin and soft-tissue infections severe enough to require hospitalization .
C0007554
cefotaxime
C0149778
soft-tissue